Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific Extends EndoTex Purchase Option; NexStent Evaluated

This article was originally published in The Gray Sheet

Executive Summary

EndoTex Interventional Systems is planning an early 2004 launch of its self-expanding NexStent carotid stent outside the U.S., using Boston Scientific as exclusive distributor under an extended agreement between the firms
Advertisement

Related Content

NexStent launches in Europe
NexStent launches in Europe
Carotid endarterectomy surgery
Carotid endarterectomy surgery
Boston Scientific Adds To Carotid Pipeline With Endotex Nexstent
Boston Scientific Adds To Carotid Pipeline With Endotex Nexstent
Advertisement
UsernamePublicRestriction

Register

MT018418

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel